Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000661984 | SCV000784315 | uncertain significance | Cardiac valvular dysplasia, X-linked | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000661985 | SCV000784316 | uncertain significance | FG syndrome 2 | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000661986 | SCV000784317 | uncertain significance | Frontometaphyseal dysplasia 1 | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000661987 | SCV000784318 | uncertain significance | Heterotopia, periventricular, X-linked dominant | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000661988 | SCV000784319 | uncertain significance | Melnick-Needles syndrome | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000661989 | SCV000784320 | uncertain significance | Terminal osseous dysplasia-pigmentary defects syndrome | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001766436 | SCV001989966 | uncertain significance | not provided | 2019-05-21 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Ce |
RCV001766436 | SCV004165133 | uncertain significance | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | FLNA: PP2 |